EVALUATION BACKGROUND, PURPOSE AND QUESTIONS
Control and Prevention of Malaria (CAP-M) is the flagship project of the President’s Malaria Initiative (PMI) in the Greater Mekong Sub-region (GMS), running from October 2011 to October 2016. The University Research Co., LLC (URC) is the primary implementing agency. Kenan Institute of Asia (KIA) is the implementing sub-partner in Thailand, and Save the Children (SCI) and Myanmar Medical Association (MMA) are the sub-partners in Burma, all of which work closely with National Malaria Control Programs (NMCPs) and the many partners working on malaria control. The overall aim of the CAP-M project is to reduce morbidity and mortality from malaria in the GMS and to eliminate artemisinin-resistant parasites. This midterm evaluation covered the first half of the overall program and aimed to assess project performance and progress towards intended results; it was conducted in Burma, Cambodia and Thailand from March-April, 2014. The evaluation, funded by the United States Agency for International Development (USAID) Regional Development Mission for Asia (RDMA), will be used to inform the second half of the project (2014-16) and allow for programmatic changes mid-term. The review consisted of 1) comprehensive review of available project materials 2) field visits for informal semistructured interviews of key informants including project staff at national/regional/local levels, plus targeted populations and 3) triangulation of quantitative data with qualitative results, to allow wideranging analysis and recommendations.
The key populations at risk for malaria within the GMS are highly mobile and migrant populations (MMPs) with exposures or occupations in forested and border areas. These populations are generally socially, geographically and economically marginalized, with consequent limited access to health services.
This evaluation focused on five major queries: